Trial Profile
Lamivadin plus adefovir compared with entecavir decompensated HBV-related cirrhosis :a prospective randomized controlled trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2013
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 28 Feb 2011 to 1 Mar 2012 as reported by Chinese Clinical Trial Register.
- 04 Oct 2010 New trial record